US Covid-19: US FDA approves Pfizer's Paxlovid pill for at home treatment of Covid-19


Share:

The US Food and Drug Administration on Wednesday authorised Pfizer's Paxlovid pill, the first anti-Covid-19 treatment pill to be authorised in the country. It will be used to treat high-risk patients with moderate to severe disease within five days of symptom onset. Pfizer said it was ready to commence delivery of the pill immediately.

The latest news comes on the back of seperate positive pandemic developments. Namely, a recent study released by Scottish scientists showed Omicron infection to be associated with about a two-thirds reduced risk of hospitalisation, a conclusion in fitting with similar studies conducted in South Africa.

Market Reaction

Markets have switched from trading in a quite a subdued fashion earlier in the session to more of a risk on mode in recent trade, with stocks, crude oil and risk sensitive currencies all gaining in recent trade. The aforementioned positive pandemic newsflow is likely contributing to a sense of optimism that while Omicron is a threat to the global economy, it does not look set to deliver a lasting blow to growth, given its lesser severity, high vaccination rates in developed countries and the upcoming rollout of effective treatments. 

Share: Feed news

Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer. Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. Risk Disclosure: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts.

Follow us on Telegram

Stay updated of all the news

Join Telegram

Recommended content


Follow us on Telegram

Stay updated of all the news

Join Telegram

Recommended content

Editors’ Picks

EUR/USD stays in daily range above 1.0800 after US PMI data

EUR/USD stays in daily range above 1.0800 after US PMI data

EUR/USD continues to fluctuate in its daily range above 1.0800 in the American session on Friday. The data from the US showed that ISM Manufacturing PMI declined more than expected in February, making it difficult for the US Dollar to gather strength.

EUR/USD News

GBP/USD holds above 1.2600 as USD struggles to gather strength

GBP/USD holds above 1.2600 as USD struggles to gather strength

GBP/USD staged a modest rebound after testing 1.2600 on Friday. Following the weaker-than-expected ISM Manufacturing PMI data from the US, the US Dollar struggles to preserve its strength and allows the pair pull away from session lows.

GBP/USD News

Gold jumps to fresh two-month high above $2,070

Gold jumps to fresh two-month high above $2,070

Gold gathered bullish momentum in the second half of the day on Friday and reached its highest level since early January above $2,070. The benchmark 10-year US Treasury bond yield is down 1% at 4.2%, fueling XAU/USD's rally ahead of the weekend.

Gold News

XRP surges to $0.62 ahead of key trial in class action lawsuit against Ripple

XRP surges to $0.62 ahead of key trial in class action lawsuit against Ripple

XRP price inched closer to its 2024 high, rallying past the $0.62 level on Thursday. The altcoin was hit by a correction, however, which pulled it back down to the $0.59s early Friday. 

Read more

Week ahead: ECB decision and US Payrolls to steal the show

Week ahead: ECB decision and US Payrolls to steal the show

Nonfarm payrolls and Powell’s testimony will be crucial for US dollar. European Central Bank could set the stage for summer rate cuts. Bank of Canada decision and UK budget announcement also in focus.

Read more

Forex MAJORS

Cryptocurrencies

Signatures